Sauer J M, Waalkes M P, Hooser S B, Kuester R K, McQueen C A, Sipes I G
Department of Pharmacology and Toxicology, Center for Toxicology, The University of Arizona, Tucson 85721-0207, USA.
Toxicology. 1997 Aug 15;121(2):155-64. doi: 10.1016/s0300-483x(97)00062-0.
Exposure of humans to toxic metals and metalloids is a major environmental problem. Many metals, such as cadmium, can be hepatotoxic. However, the mechanisms by which metals cause acute hepatic injury are in many cases unknown. Previous reports suggest a major role for inflammation in acute cadmium induced hepatotoxicity. In initial experiments we found that a non-hepatotoxic dose of cadmium chloride (CdCl2; 2.0 mg/kg, i.v.) markedly increased the clearance rate of colloidal carbon from the blood, which is indicative of enhanced phagocytic activity by Kupffer cells (resident hepatic macrophages). Thus. the objective these studies was to determine the involvement of Kupffer cells in cadmium induced liver injury by inhibiting their function with gadolinium chloride (GdCl3). Male Sprague-Dawley rats were administered GdCl3 (10 mg/kg, i.v.) followed 24 h later by a single dose of CdCl2 (3.0 and 4.0 mg/kg, i.v.). Twenty four hours after CdCl2 administration animals were killed and the degree of liver toxicity was assessed using plasma alanine aminotransferase (ALT), as well as light microscopy. Cadmium chloride administration produced multifocal hepatocellular necrosis and increased plasma ALT activity. Pretreatment with GdCl3 significantly reduced both the morphological changes and hepatic ALT release caused by CdCl2. However, the protection was specific to the liver, and did not alter CdCl2 induced testicular injury, as determined by histopathological damage. In many cases, the inducible cadmium-binding protein, metallothionein (MT) is often an essential aspect of the acquisition of cadmium tolerance in the liver. Although cadmium caused a dramatic induction of hepatic MT (32-fold), GdCl3 caused only a minor increase (2-fold). Combined CdCl2 and GdCl3 treatment did not induce levels to an extent greater than CdCl2 alone. As expected, GdCl3 also caused a slight increase in the amount of cadmium associated with the liver. In cultured hepatocytes isolated from GdCl3 pretreated rats, CdCl2 induced cytotoxicity was not significantly altered compared to control hepatocytes, indicating that the mechanism of tolerance required the presence of other cell types. Thus, GdCl3 attenuation of CdCl2 induced hepatotoxicity does not appear to be caused by increased tissue MT content or a decreased susceptibility of hepatocytes to cadmium. From these data, we concluded that tolerance to cadmium induced hepatotoxicity involves the inhibition of Kupffer cell function which results in a decreased inflammatory response and an altered progression of hepatic injury. These data further indicate that Kupffer cell function is critical to cadmium induced hepatocellular necrosis.
人类接触有毒金属和类金属是一个重大的环境问题。许多金属,如镉,具有肝毒性。然而,在很多情况下,金属导致急性肝损伤的机制尚不清楚。先前的报告表明炎症在急性镉诱导的肝毒性中起主要作用。在初步实验中,我们发现非肝毒性剂量的氯化镉(CdCl2;2.0 mg/kg,静脉注射)显著提高了血液中胶体碳的清除率,这表明库普弗细胞(驻留肝巨噬细胞)的吞噬活性增强。因此,这些研究的目的是通过用氯化钆(GdCl3)抑制库普弗细胞的功能来确定其在镉诱导的肝损伤中的作用。给雄性Sprague-Dawley大鼠静脉注射GdCl3(10 mg/kg),24小时后再静脉注射单剂量的CdCl2(3.0和4.0 mg/kg)。在注射CdCl2 24小时后处死动物,使用血浆丙氨酸转氨酶(ALT)以及光学显微镜评估肝毒性程度。注射氯化镉导致多灶性肝细胞坏死并增加血浆ALT活性。用GdCl3预处理可显著减轻CdCl2引起的形态学变化和肝ALT释放。然而,这种保护作用仅限于肝脏,并不改变CdCl2诱导的睾丸损伤,这通过组织病理学损伤得以确定。在很多情况下,可诱导的镉结合蛋白金属硫蛋白(MT)通常是肝脏获得镉耐受性的一个重要方面。尽管镉可显著诱导肝脏MT(32倍),但GdCl3仅引起轻微增加(2倍)。联合使用CdCl2和GdCl3治疗并未使诱导水平高于单独使用CdCl2的情况。正如预期的那样,GdCl3还导致肝脏中镉的含量略有增加。在从GdCl3预处理大鼠分离的培养肝细胞中,与对照肝细胞相比,CdCl2诱导的细胞毒性没有显著改变,这表明耐受性机制需要其他细胞类型的存在。因此,GdCl3减轻CdCl2诱导的肝毒性似乎不是由组织MT含量增加或肝细胞对镉的敏感性降低引起的。根据这些数据,我们得出结论,对镉诱导的肝毒性的耐受性涉及抑制库普弗细胞功能,这导致炎症反应减少和肝损伤进程改变。这些数据进一步表明库普弗细胞功能对镉诱导的肝细胞坏死至关重要。